Sec Form 4 Filing - DUGGAN ROBERT W @ PHARMACYCLICS INC - 2015-05-26

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person DUGGAN ROBERT W 2. Issuer Name and Ticker or Trading Symbol PHARMACYCLICS INC [ PCYC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chairman and CEO (Last) (First) (Middle) C/O PHARMACYCLICS, INC., 995 EAST ARQUES AVENUE 3. Date of Earliest Transaction (MM/DD/YY) 05/26/2015 (Street) SUNNYVALE, CA94085 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/17/2015 G V 152,635 D $ 0 13,230,316 D Common Stock 03/18/2015 G V 4,785 D $ 0 13,225,531 ( 1 ) D ( 1 ) Common Stock 05/26/2015 U 13,225,531 ( 1 ) D $ 261.25 ( 2 ) 0 D Common Stock 05/26/2015 U 21,908 D $ 261.25 ( 2 ) 0 I By Trust ( 3 ) ( 4 ) Common Stock 05/26/2015 U 21,908 D $ 261.25 ( 2 ) 0 I By Trust ( 3 ) ( 5 ) Common Stock 05/26/2015 U 21,908 D $ 261.25 ( 2 ) 0 I By Trust ( 3 ) ( 6 ) Common Stock 05/26/2015 U 21,908 D $ 261.25 ( 2 ) 0 I By Trust ( 3 ) ( 7 ) Common Stock 05/26/2015 U 21,908 D $ 261.25 ( 2 ) 0 I By Trust ( 3 ) ( 8 ) Common Stock 05/26/2015 U 21,908 D $ 261.25 ( 2 ) 0 I By Trust ( 3 ) ( 9 ) Common Stock 05/26/2015 U 21,908 D $ 261.25 ( 2 ) 0 I By Trust ( 3 ) ( 10 ) Common Stock 05/26/2015 U 8,404 D $ 261.25 ( 2 ) 0 I By Child ( 3 ) Common Stock 05/26/2015 U 8,404 D $ 261.25 ( 2 ) 0 I By Child ( 3 ) Common Stock 05/26/2015 U 8,404 D $ 261.25 ( 2 ) 0 I By Child ( 3 ) Common Stock 05/26/2015 U 8,404 D $ 261.25 ( 2 ) 0 I By Child ( 3 ) Common Stock 05/26/2015 U 8,404 D $ 261.25 ( 3 ) 0 I By Child ( 3 ) Common Stock 05/26/2015 U 170,379 D $ 261.25 ( 2 ) 0 I Managed Accounts ( 11 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other DUGGAN ROBERT W C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVENUE SUNNYVALE, CA94085 X X Chairman and CEO Signatures /s/ Robert W. Duggan 05/27/2015 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Includes (i) 1,020,756 shares owned by Mr. Duggan's spouse; (ii) 5,421 shares owned by Blazon Corp. ("Blazon"), as the sole stockholder of Blazon, Mr. Duggan may be de emed to beneficially own the shares owned by Blazon; (iii) 283,784 shares owned by MultiAccess Computing Corp. ("MultiAccess"), as the sole stockholder of MultiAccess, Mr. Duggan may be deemed to beneficially own the shares owned by MultiAccess,; (iv) 161,760 shares held in irrevocable trusts for the benefit of Mr. Duggan's children (for which neither Mr. Duggan nor any immediate family members of Mr. Duggan are trustees) as additionally individually listed in the boxes below and as further described in footnotes 2 through 9; and (v) 42,020 shares directly owned by certain of Mr. Duggan's children as additionally individually listed in the boxes below. Mr. Duggan disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. ( 2 )Price reflects aggregate per share consideration paid pursuant to the Tender Offer. ( 3 )Mr. Duggan disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein. ( 4 )Shares directly owned by David Michael Duggan Trust, an irrevocable trust. Neither Mr. Duggan nor any immediate family members of Mr. Duggan are trustees of the David Michael Duggan Trust. ( 5 )Shares directly owned by Daniel Douglas Duggan Trust, an irrevocable trust. Neither Mr. Duggan nor any immediate family members of Mr. Duggan are trustees of the Daniel Douglas Duggan Trust. ( 6 )Shares directly owned by Dylan Duke Duggan Trust, an irrevocable trust. Neither Mr. Duggan nor any immediate family members of Mr. Duggan are trustees of the Dylan Duke Duggan Trust. ( 7 )Shares directly owned by Diamond Augustus Duggan Trust, an irrevocable trust. Neither Mr. Duggan nor any immediate family members of Mr. Duggan are trustees of the Diamond Augustus Duggan Trust. ( 8 )Shares directly owned by Dante Eon Duggan Trust, an irrevocable trust. Neither Mr. Duggan nor any immediate family members of Mr. Duggan are trustees of the Dante Eon Duggan Trust. ( 9 )Shares directly owned by Dsara Ann Duggan Trust, an irrevocable trust. Neither Mr. Duggan nor any immediate family members of Mr. Duggan are trustees of the Dsara Ann Duggan Trust. ( 10 )Shares directly owned by Diana Star Duggan Trust, an irrevocable trust. Neither Mr. Duggan nor any immediate family members of Mr. Duggan are trustees of the Diana Star Duggan Trust. ( 11 )Shares held in managed accounts pursuant to agreements with Robert W. Duggan & Associates ("RWD&A"), of which Robert W. Duggan is a principal. Mr. Duggan disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.